You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR Phase II:A New Class of High-Conductivity Solid-state Composite Electrolytes for Next-Generation Lithium Batteries

    SBC: NEXTGEN BATTERY TECHNOLOGIES, LLC            Topic: EN

    The broader impact/commercial potential of this Small Business Innovative Research (SBIR) Phase II project is the introduction of non-flammable, easy-to-manufacture solid battery electrolytes that are also compatible with lithium metal. The cell architecture seeks to ensure safety while enabling a significant improvement in the energy density.The teams also seeks to lower the costs of the lithium- ...

    SBIR Phase II 2022 National Science Foundation
  2. SBIR Phase I:Applying Machine Learning to Mitigate Disruptions in Novel Relay Trucking Model

    SBC: CONNECT DYNAMICS, INC.            Topic: MO

    The broader impacts of this SBIR Phase I project include a more sustainable and profitable trucking industry, enhanced conditions for the trucking workforce, improved public road safety, reduced emissions, and a path to future advancements using alternative energy and autonomous technologies. This project centers on a patented technology that pools shipments and matches tractors and drivers with t ...

    SBIR Phase I 2022 National Science Foundation
  3. SBIR Phase I:A Blockchain-Driven, Distributed Memory, Computational Platform for Industrial Analytics

    SBC: Blockalytics LLC            Topic: DL

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide a novel, predictive analytics technology for industrial enterprises that require low-latency analytics insights, i.e., companies that cannot afford the kind of delayed insights that are widely present in almost all Cloud-based analytics solutions. Large manufacturing and energy e ...

    SBIR Phase I 2022 National Science Foundation
  4. STTR Phase I: A pediatric care platform to enable personalized and coordinated developmental and behavioral care for children

    SBC: Bloomalo LLC            Topic: DH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project targets the critical need and gap in developmental and behavioral care for children and families. Up to 1 in 5 children have some type of behavioral and/or developmental problem that requires diagnosis. Of these, 80% are likely to have insufficient behavioral or developmental care. There conti ...

    STTR Phase I 2022 National Science Foundation
  5. F plus G RSV VLP Vaccine for Improved Safety and Efficacy

    SBC: RAZI PHARMA LLC            Topic: NIAID

    Project Summary Respiratory syncytial virus (RSV) is a leading cause of serious lower respiratory tract disease in infants and young children worldwide. Since infection induces only partial protection, it causes repeat infection and disease throughout life. Though a high priority for vaccine development no vaccine is yet available. The lack of success in developing a vaccine suggests novel strateg ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  6. Neural Stem Cell Extracellular Vesicle Treatment for Traumatic Brain Injury

    SBC: ARUNA BIO, INC.            Topic: NINDS

    Project Summary/AbstractTraumatic brain injury (TBI) is a universal health concern and is known as a “silent epidemic”. Each year in America, 2.53 million patients visit the emergency department after suffering a TBI of which 56,800 die and over 288,000 require hospitalization, rehabilitation programs, and long-term supportive care. Although the primary TBI event is typically acute, subsequent ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  7. Microwave-Enhanced Microreactor for Ultrafast Detection of Protein Biomarkers

    SBC: VIC FOUNDRY INC            Topic: 400

    Project Summary In diagnosis, risk stratification, and management of life-threatening diseases/conditions, every minute counts and unambiguous detection of many relevant protein biomarkers is crucial. Unfortunately, the workflow of current unambiguous approach–mass spectrometry–is bottlenecked by the sample preparation process. A microwave-enhanced, flow-through microreactor is proposed here f ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  8. Colon cancer prevention with non-systemic PDE5 inhibitors

    SBC: Targut Biotechnologies Inc.            Topic: 102

    Approximately 50,000 people will die from colorectal cancer (CRC) in the United States this year due to the late stage at diagnosis where treatments are largely ineffective. Primary prevention of CRC is therefore very important for high-risk patients. Chemoprevention agents are needed for CRC but nothing has been approved for this purpose. Extensive preclinical and epidemiological evidence show gr ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  9. A Precision Medicine Tool for Optimal Personalized Treatment in Patients with Acute Myeloid Leukemia

    SBC: SANICKA, INC            Topic: NCI

    Acute myeloid leukemia (AML) is an aggressive cancer of the bone marrow and peripheral blood with poor prognosis mostly due to relapse. Despite decades of improvements in chemo-immunotherapy (CIT) and, more recently, the use of hypomethylating agent (HMAs) and addition of novel small molecule inhibitors (SMIs) to back-bone chemotherapy, AML treatment selection and dosage remains mostly empiric, wi ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  10. Development of a comprehensive suite of research-backed, integrated educational tools to inspire, educate, train, and support academic entrepreneurs in the commercialization of university research.

    SBC: CONTINUUM EDUCATIONAL TECHNOLOGIES, PBC            Topic: 500

    PROJECT SUMMARY Continuum Educational Technologies’ (Continuum) will work with the University of Kansas (KU) on the proposed I-RED program entitled Smart Tools to Accelerate Research Translation by Uplifting Participants for the Central IDeA State Region (STARTUP Central) program to stimulate technological innovation in the IDeA state regions by addressing the entrepreneurial educational needs o ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government